Page last updated: 2024-09-05

n-(3-pyridylmethyl)adriamycin and Esophageal Neoplasms

n-(3-pyridylmethyl)adriamycin has been researched along with Esophageal Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Abbaszadegan, MR; Ardalan Khales, S; Forghanifard, MM; Hosseini, SE1
Asadi, J; Jafari, SM; Mohammadi, Z; Ramedani, F; Saghaeian Jazi, M1
Asadi, J; Jazi, MS; Khosravi, A; Kokabi, F1

Other Studies

3 other study(ies) available for n-(3-pyridylmethyl)adriamycin and Esophageal Neoplasms

ArticleYear
EZH2 deregulates BMP, Hedgehog, and Hippo cell signaling pathways in esophageal squamous cell carcinoma.
    Advances in medical sciences, 2023, Volume: 68, Issue:1

    Topics: Cell Line, Tumor; Cell Proliferation; Enhancer of Zeste Homolog 2 Protein; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation, Neoplastic; Humans; Signal Transduction

2023
Anti-cancer effect of entacaponeon esophageal cancer cells via apoptosis induction and cell cycle modulation.
    Cancer reports (Hoboken, N.J.), 2023, Volume: 6, Issue:3

    Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Apoptosis; Catechol O-Methyltransferase; Cell Cycle; Esophageal Neoplasms; Humans; Leukocytes, Mononuclear

2023
A reliable mouse model of liver and lung metastasis by injecting esophageal cancer stem cells (CSCs) through tail-vein injection.
    Molecular biology reports, 2023, Volume: 50, Issue:4

    Topics: Animals; Cell Line, Tumor; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Liver; Lung Neoplasms; Mice; Mice, Nude; Neoplastic Stem Cells

2023